Fundraising Fox

Clearside Biomedical

Alpharetta, US · Delaware corporation · 4 known investors

clearsidebio.com ↗
Biotech

Founders & leadership

WH
William HumphriesDirector
GC
Gerald Cagle, Ph.D.Director
EZ
Evgeny ZaytsevDirector
DY
Derek YoonDirector
CL
Christy L. Shaffer, Ph.D.Director
CD
Charles DeignanExecutive Officer
GN
Glenn NoronhaExecutive Officer
DH
Daniel H. WhiteExecutive Officer, Director
RC
Richard CroarkinDirector
CB
Clay B. ThorpDirector

Investors · 4

Mountain Group CapitalNashville
Solasta VenturesBoston
HatterasreportedRaleigh
Hatteras Venture Partnersreported · 2 sourcesResearch Triangle · $500K – $4Mvia Clay Thorp · board

Reported raises · per SEC filings

Form D private placements
▶$3.3MraisedDec 2019 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • George LasezkayExecutive Officer, Director
  • Charles A. DeignanExecutive Officer
  • William D. HumphriesDirector
  • Clay B. ThorpDirector
  • Jeffrey L. EdwardsDirector
  • Christy ShafferDirector
  • Richard CroarkinDirector
Offering amount
$3.3M
Amount sold
$3.3M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$320KraisedOct 2016 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • William D. HumphriesDirector
  • Gerald Cagle, Ph.D.Director
  • Evgeny ZaytsevDirector
  • Derek YoonDirector
  • Christy L. Shaffer, Ph.D.Director
  • Charles DeignanExecutive Officer
  • Glenn NoronhaExecutive Officer
  • Clay B. ThorpDirector
  • Daniel H. WhiteExecutive Officer, Director
  • Richard CroarkinDirector
Offering amount
$320K
Amount sold
$320K
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.4MraisedDec 2015 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charlie DeignanExecutive Officer
  • Clay ThorpDirector
  • William HumphriesDirector
  • Evgeny ZaytsevDirector
  • Christy ShafferDirector
  • Daniel WhiteExecutive Officer, Director, Promoter
  • Gerald D. CagleDirector
Offering amount
$20M
Amount sold
$14.4M
First sale
Nov 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.